EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mavacamten in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Patient-Reported Health Status Analysis up to 78 Weeks in the EXPLORER-CN Study

Zhuang Tian, Xiaoyan Li, Liwen Li, Qing Zhang, Jian'an Wang, Yunqi Shi, Daoquan Peng, Wei Ma, Ping Yang, Xiang Cheng, Wei Jin, Fang Wang und 7 weitere

Cardiology and Therapy · 2026-06 · 15 (2) · 185-200

DOI: 10.1007/s40119-026-00449-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology and Therapy, online erschienen am 21.05.2026. Verfasst von Zhuang Tian und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuy…. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai LianBio Development Co., Ltd, Bristol-Myers Squibb.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ChinaHealth statusKCCQMavacamtenProlonged exposureSymptomatic obstructive hypertrophic cardiomyopathy

Autor:innen und Institutionen

  • Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Wangfujing Dongcheng District, Beijing, 100730, China.
  • Department of Cardiology, Renmin Hospital of Wuhan University, Hubei General Hospital, Wuhan, China.
  • Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Cardiology, The People's Hospital of Liaoning Province, Shenyang, China.

Förderung

  • Shanghai LianBio Development Co., Ltd
  • Bristol-Myers Squibb

Zitieren

APA

Tian, Z., Li, X., Li, L., Zhang, Q., Wang, J., Shi, Y., Peng, D., Ma, W., Yang, P., Cheng, X., Jin, W., Wang, F., Memaj, A., Xie, Y., Pan, B., Florea, V., Zheng, J., Zhong, Y., & Zhang, S. (2026). Mavacamten in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Patient-Reported Health Status Analysis up to 78 Weeks in the EXPLORER-CN Study. Cardiology and Therapy, 15(2), 185-200. https://doi.org/10.1007/s40119-026-00449-5

Vancouver

Tian Z, Li X, Li L, Zhang Q, Wang J, Shi Y, et al. Mavacamten in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Patient-Reported Health Status Analysis up to 78 Weeks in the EXPLORER-CN Study. Cardiology and Therapy. 2026;15(2):185-200. doi:10.1007/s40119-026-00449-5

BibTeX
@article{Tian2026,
  author = {Tian, Zhuang and Li, Xiaoyan and Li, Liwen and Zhang, Qing and Wang, Jian'an and Shi, Yunqi and Peng, Daoquan and Ma, Wei and Yang, Ping and Cheng, Xiang and Jin, Wei and Wang, Fang and Memaj, Arteid and Xie, Yimeng and Pan, Beth and Florea, Victoria and Zheng, Jing and Zhong, Yue and Zhang, Shuyang},
  title = {Mavacamten in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Patient-Reported Health Status Analysis up to 78 Weeks in the EXPLORER-CN Study},
  journal = {Cardiology and Therapy},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {185--200},
  doi = {10.1007/s40119-026-00449-5}
}
Kostenlos starten →